-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$59.3321089.29% Upside
Bionano Genomics, Inc. Frequently Asked Questions
-
What analysts cover Bionano Genomics, Inc.?
Bionano Genomics, Inc. has been rated by research analysts at Scotiabank, BTIG, EF Hutton in the past 90 days.